1st -line treatment of patients with mantle cell lymphoma: Treatment reality and first outcome data from the German prospective TLN Registry.

Knauf, W., Bertram, Fietz, T., Kirste, T., Grugel, R., Schnitzler, Abenhardt, W., 2016.

Oncol Res Treat 39 (suppl 3)(V364), 120. doi:10.1159/000449050

Studie: TLN; Indikation: Hämoblastosen; Jahr: 2016; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com